Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical Cancer.

Journal of immunotherapy and precision oncology（2023）

引用 0|浏览19

暂无评分

摘要

Bone metastasis and absolute lymphocyte count below normal range at phase I study entry portend poor survival in patients with recurrent or metastatic cervical cancer.

查看译文

关键词

lymphopenia,metastatic cervical cancer,phase I trial prognosis,recurrent cervical cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要